 | • レポートコード：QYR9ST03428 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、B型肝炎及びC型肝炎診断の世界市場について調査・分析し、B型肝炎及びC型肝炎診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（B型肝炎、C型肝炎）、用途別（免疫診断、核酸検査（NAT））、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のB型肝炎及びC型肝炎診断市場動向 ・主要企業別マーケットシェア ・B型肝炎及びC型肝炎診断の種類別市場規模2014-2019 （B型肝炎、C型肝炎） ・B型肝炎及びC型肝炎診断の用途別市場規模2014-2019 （免疫診断、核酸検査（NAT）） ・B型肝炎及びC型肝炎診断の北米市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断の中国市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断の日本国内市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断のインド市場：主要企業・種類別/用途別市場規模 ・B型肝炎及びC型肝炎診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche Diagnostics、Abbott、Siemens、Qiagen、Alere、bioMérieux、Cepheid、Chembio Diagnostics、DiaSorin、Enzo Life Sciences、Hologic、MedMira、OraSure Technologies、Quest Diagnostics、Quidel Corp、Randox Laboratories） ・B型肝炎及びC型肝炎診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
In 2018, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B and C Diagnostics development in United States, Europe and China.
The key players covered in this study
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Market segment by Type, the product can be split into
Hepatitis B
Hepatitis C
Market segment by Application, split into
Immunodiagnostics
Nucleic Acid Test (NAT)
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis B and C Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Hepatitis B
1.4.3 Hepatitis C
1.5 Market by Application
1.5.1 Global Hepatitis B and C Diagnostics Market Share by Application (2014-2025)
1.5.2 Immunodiagnostics
1.5.3 Nucleic Acid Test (NAT)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hepatitis B and C Diagnostics Market Size
2.2 Hepatitis B and C Diagnostics Growth Trends by Regions
2.2.1 Hepatitis B and C Diagnostics Market Size by Regions (2014-2025)
2.2.2 Hepatitis B and C Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hepatitis B and C Diagnostics Market Size by Manufacturers
3.1.1 Global Hepatitis B and C Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis B and C Diagnostics Key Players Head office and Area Served
3.3 Key Players Hepatitis B and C Diagnostics Product/Solution/Service
3.4 Date of Enter into Hepatitis B and C Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hepatitis B and C Diagnostics Market Size by Type (2014-2019)
4.2 Global Hepatitis B and C Diagnostics Market Size by Application (2014-2019)
5 United States
5.1 United States Hepatitis B and C Diagnostics Market Size (2014-2019)
5.2 Hepatitis B and C Diagnostics Key Players in United States
5.3 United States Hepatitis B and C Diagnostics Market Size by Type
5.4 United States Hepatitis B and C Diagnostics Market Size by Application
6 Europe
6.1 Europe Hepatitis B and C Diagnostics Market Size (2014-2019)
6.2 Hepatitis B and C Diagnostics Key Players in Europe
6.3 Europe Hepatitis B and C Diagnostics Market Size by Type
6.4 Europe Hepatitis B and C Diagnostics Market Size by Application
7 China
7.1 China Hepatitis B and C Diagnostics Market Size (2014-2019)
7.2 Hepatitis B and C Diagnostics Key Players in China
7.3 China Hepatitis B and C Diagnostics Market Size by Type
7.4 China Hepatitis B and C Diagnostics Market Size by Application
8 Japan
8.1 Japan Hepatitis B and C Diagnostics Market Size (2014-2019)
8.2 Hepatitis B and C Diagnostics Key Players in Japan
8.3 Japan Hepatitis B and C Diagnostics Market Size by Type
8.4 Japan Hepatitis B and C Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hepatitis B and C Diagnostics Market Size (2014-2019)
9.2 Hepatitis B and C Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Hepatitis B and C Diagnostics Market Size by Type
9.4 Southeast Asia Hepatitis B and C Diagnostics Market Size by Application
10 India
10.1 India Hepatitis B and C Diagnostics Market Size (2014-2019)
10.2 Hepatitis B and C Diagnostics Key Players in India
10.3 India Hepatitis B and C Diagnostics Market Size by Type
10.4 India Hepatitis B and C Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Hepatitis B and C Diagnostics Market Size (2014-2019)
11.2 Hepatitis B and C Diagnostics Key Players in Central & South America
11.3 Central & South America Hepatitis B and C Diagnostics Market Size by Type
11.4 Central & South America Hepatitis B and C Diagnostics Market Size by Application
12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hepatitis B and C Diagnostics Introduction
12.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hepatitis B and C Diagnostics Introduction
12.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 Siemens
12.3.1 Siemens Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hepatitis B and C Diagnostics Introduction
12.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.3.5 Siemens Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hepatitis B and C Diagnostics Introduction
12.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.4.5 Qiagen Recent Development
12.5 Alere
12.5.1 Alere Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hepatitis B and C Diagnostics Introduction
12.5.4 Alere Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.5.5 Alere Recent Development
12.6 bioMérieux
12.6.1 bioMérieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hepatitis B and C Diagnostics Introduction
12.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.6.5 bioMérieux Recent Development
12.7 Cepheid
12.7.1 Cepheid Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hepatitis B and C Diagnostics Introduction
12.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.7.5 Cepheid Recent Development
12.8 Chembio Diagnostics
12.8.1 Chembio Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hepatitis B and C Diagnostics Introduction
12.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.8.5 Chembio Diagnostics Recent Development
12.9 DiaSorin
12.9.1 DiaSorin Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hepatitis B and C Diagnostics Introduction
12.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.9.5 DiaSorin Recent Development
12.10 Enzo Life Sciences
12.10.1 Enzo Life Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hepatitis B and C Diagnostics Introduction
12.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.10.5 Enzo Life Sciences Recent Development
12.11 Hologic
12.12 MedMira
12.13 OraSure Technologies
12.14 Quest Diagnostics
12.15 Quidel Corp
12.16 Randox Laboratories
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hepatitis B and C Diagnostics Key Market Segments
Table Key Players Hepatitis B and C Diagnostics Covered
Table Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Type 2014-2025
Figure Hepatitis B Figures
Table Key Players of Hepatitis B
Figure Hepatitis C Figures
Table Key Players of Hepatitis C
Table Global Hepatitis B and C Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Immunodiagnostics Case Studies
Figure Nucleic Acid Test (NAT) Case Studies
Figure Hepatitis B and C Diagnostics Report Years Considered
Table Global Hepatitis B and C Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Share by Regions 2014-2019
Figure Global Hepatitis B and C Diagnostics Market Share by Regions 2014-2019
Figure Global Hepatitis B and C Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Hepatitis B and C Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Share by Manufacturers in 2018
Table Global Hepatitis B and C Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hepatitis B and C Diagnostics Product/Solution/Service
Table Date of Enter into Hepatitis B and C Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size Share by Type (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size Share by Application (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Hepatitis B and C Diagnostics Revenue Market Share by Application in 2018
Figure United States Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table United States Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table United States Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Europe Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Europe Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Europe Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure China Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table China Hepatitis B and C Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table China Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Japan Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Japan Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Japan Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Southeast Asia Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure India Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table India Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table India Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Central & South America Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Central & South America Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019) (Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Abbott Company Details
Table Abbott Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Abbott Recent Development
Table Siemens Company Details
Table Siemens Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Siemens Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Siemens Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Qiagen Recent Development
Table Alere Company Details
Table Alere Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Alere Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Alere Recent Development
Table bioMérieux Company Details
Table bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure bioMérieux Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table bioMérieux Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Cepheid Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Cepheid Recent Development
Table Chembio Diagnostics Company Details
Table Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Chembio Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Chembio Diagnostics Recent Development
Table DiaSorin Company Details
Table DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure DiaSorin Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table DiaSorin Recent Development
Table Enzo Life Sciences Company Details
Table Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Enzo Life Sciences Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Enzo Life Sciences Recent Development
Table Hologic Company Details
Table MedMira Company Details
Table OraSure Technologies Company Details
Table Quest Diagnostics Company Details
Table Quidel Corp Company Details
Table Randox Laboratories Company Details
Table Global Hepatitis B and C Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Hepatitis B and C Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size Share by Regions in 2025
Figure United States Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Hepatitis B and C Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size by Product (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size by Product in 2025
Table Global Hepatitis B and C Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size by Application (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
E型肝炎診断検査の世界市場：市場規模・現状・予測 Hepatitis E is a virus that affects your liver.In 2018, the global Hepatitis E Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hepatitis E Diagnostic Tests status, fu…- 世界の肝炎検査キット市場：専門的調査 The global Hepatitis Test Kits market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Hepatitis Test Kits volume and value at global level, regional level and company level. From a global perspec…
- 肝炎診断テストの世界市場：市場規模・現状・予測 Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…
- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…